{"transactions":[{"id":2924878,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-04T22:12:16.000Z","date":"2020-12-31","kind":"sale","acquired":false,"shares":4140,"price":4.1741,"value":17280.774,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average.  These shares were sold in multiple transactions at prices ranging from $4.13 to $4.32, inclusive."}],"balance_after":186282,"source":{"system":"sec-edgar","filing":"0001615594-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559421000001/primary_doc.xml","form_type":"4"}},{"id":3018054,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-10-01T21:09:50.000Z","date":"2020-09-30","kind":"sale","acquired":false,"shares":4140,"price":5.5854,"value":23123.556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average.  These shares were sold in multiple transactions at prices ranging from $5.45 to $5.74, inclusive."}],"balance_after":190422,"source":{"system":"sec-edgar","filing":"0001615594-20-000067","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000067/primary_doc.xml","form_type":"4"}},{"id":3064425,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right-to-Buy)","published_at":"2020-08-07T22:46:41.000Z","date":"2020-08-04","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant."}],"balance_after":175000,"derivative":{"exercise_price":4.55,"exercise_date":"2021-08-04","expiration_date":"2030-08-04","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001615594-20-000055","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000055/primary_doc.xml","form_type":"4"}},{"id":3072227,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-31T21:12:08.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":3495,"price":4.6547,"value":16268.1765,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average.  These shares were sold in multiple transactions at prices ranging from $4.55 to $4.9458, inclusive."}],"balance_after":194562,"source":{"system":"sec-edgar","filing":"0001615594-20-000045","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000045/primary_doc.xml","form_type":"4"}},{"id":3072226,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-31T21:12:08.000Z","date":"2020-06-29","kind":"sale","acquired":false,"shares":2902,"price":5.0075,"value":14531.765,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average.  These shares were sold in multiple transactions at prices ranging from $4.955 to $5.03, inclusive."}],"balance_after":198057,"source":{"system":"sec-edgar","filing":"0001615594-20-000045","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000045/primary_doc.xml","form_type":"4"}},{"id":3185706,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-04-02T20:21:04.000Z","date":"2020-03-31","kind":"tax_withholding","acquired":false,"shares":3177,"price":2.9553,"value":9388.9881,"ownership":{"direct":true},"balance_after":200959,"source":{"system":"sec-edgar","filing":"0001615594-20-000020","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000020/primary_doc.xml","form_type":"4"}},{"id":3470281,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2019-07-02T16:36:08.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":166667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit (PSU) represents a contingent right to receive one share of Calyxt common stock.  The PSU will vest as to 50%, 100% or 120% of the shares at the end of a three year performance period based upon increases in Calyxt common stock from the starting price of $12.48 (and on a linear basis between vesting percentages) and if vested, will be issued as restricted stock with restrictions lapsing on the two year anniversary of the date of issuance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance stock unit (PSU) represents a contingent right to receive one share of Calyxt common stock.  The PSU will vest as to 50%, 100% or 120% of the shares at the end of a three year performance period based upon increases in Calyxt common stock from the starting price of $12.48 (and on a linear basis between vesting percentages) and if vested, will be issued as restricted stock with restrictions lapsing on the two year anniversary of the date of issuance."}],"balance_after":166667,"derivative":{"expiration_date":"2022-06-28","underlying":"Common Stock","underlying_shares":166667},"source":{"system":"sec-edgar","filing":"0001615594-19-000024","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559419000024/primary_doc.xml","form_type":"4"}},{"id":3470280,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right-to-Buy)","published_at":"2019-07-02T16:36:08.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Option vests as to 15% of the underlying shares on the first anniversary of the Grant Date, as to 10% of the underlying shares on the second anniversary of the Grant Date, and as to 5% of the underlying shares on the last day of each calendar quarter beginning the first full calendar quarter after the second anniversary of the Grant Date."}],"balance_after":125000,"derivative":{"exercise_price":12.48,"exercise_date":"2020-06-28","expiration_date":"2029-06-28","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001615594-19-000024","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559419000024/primary_doc.xml","form_type":"4"}},{"id":3470279,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-07-02T16:36:08.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"50,000 Restricted Stock Units with respect to Calyxt, Inc. common stock were granted to reporting person on 6/28/2019 and vest as to 15% of the underlying shares on the first anniversary of the Grant Date, as to 10% of the underlying shares on the second anniversary of the Grant Date, and as to 5% of the underlying shares on the last day of each calendar quarter beginning on the first full calendar quarter after the second anniversary of the Grant Date."}],"balance_after":204136,"source":{"system":"sec-edgar","filing":"0001615594-19-000024","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559419000024/primary_doc.xml","form_type":"4"}},{"id":3562298,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-04T20:07:59.000Z","date":"2019-04-02","kind":"sale","acquired":false,"shares":2582,"price":16.6468,"value":42982.0376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.56 to $16.85, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 135,000 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on September 17, 2018 and remain unvested; 27,000 shares will vest on the October 1, 2019, and the remainder vesting quarterly (commencing with the fourth fiscal quarter of 2019) in equal installments over 36 months."}],"balance_after":154136,"source":{"system":"sec-edgar","filing":"0001127602-19-014799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219014799/form4.xml","form_type":"4"}},{"id":3576221,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-27T20:22:19.000Z","date":"2019-03-26","kind":"sale","acquired":false,"shares":2582,"price":17.8656,"value":46128.9792,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The award of restricted stock units with respect to Calyxt, Inc. common stock was granted on September 17, 2018 and vested 25% on October 1, 2018, with 15% vesting on October 1, 2019, and the remainder vesting quarterly (commencing with the fourth fiscal quarter of 2019) in equal installments over 36 months."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.64 to $18.09, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4."}],"balance_after":156718,"source":{"system":"sec-edgar","filing":"0001127602-19-013430","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219013430/form4.xml","form_type":"4"}},{"id":3584231,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-21T01:26:33.000Z","date":"2019-03-19","kind":"sale","acquired":false,"shares":2582,"price":17.3172,"value":44713.0104,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The award of restricted stock units with respect to Calyxt, Inc. common stock was granted on September 17, 2018 and vested 25% on October 1, 2018, with 15% vesting on October 1, 2019, and the remainder vesting quarterly (commencing with the fourth fiscal quarter of 2019) in equal installments over 36 months."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.02 to $17.63, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":159300,"source":{"system":"sec-edgar","filing":"0001127602-19-012485","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219012485/form4.xml","form_type":"4"}},{"id":3592257,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-15T20:03:41.000Z","date":"2019-03-12","kind":"sale","acquired":false,"shares":2582,"price":16.5772,"value":42802.3304,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The award of restricted stock units with respect to Calyxt, Inc. common stock was granted on September 17, 2018 and vested 25% on October 1, 2018, with 15% vesting on October 1, 2019, and the remainder vesting quarterly (commencing with the fourth fiscal quarter of 2019) in equal installments over 36 months."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $17.26, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":161882,"source":{"system":"sec-edgar","filing":"0001127602-19-011547","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219011547/form4.xml","form_type":"4"}},{"id":3655841,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-14T21:56:08.000Z","date":"2018-10-01","kind":"tax_withholding","acquired":false,"shares":15536,"price":14.83,"value":230398.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The award of restricted stock units with respect to Calyxt, Inc. common stock was granted on September 17, 2018 and vested 25% on October 1, 2018, with 15% vesting on October 1, 2019, and the remainder vesting quarterly (commencing with the fourth fiscal quarter of 2019) in equal installments over 36 months."}],"balance_after":164464,"source":{"system":"sec-edgar","filing":"0001127602-19-006028","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219006028/form5.xml","form_type":"5"}},{"id":3793222,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":144202,"kind":"person","name":"Blome James","position":1,"cik":"0001753563","reported_name":"Blome James","relationship":{"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-10T21:20:37.000Z","date":"2018-10-08","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option was granted on October 8, 2018 and vests 15% on October 8, 2019 and 15% on October 8, 2020, with the remainder vesting quarterly (commencing with the first fiscal quarter of 2021) in equal installments over 42 months."}],"balance_after":200000,"derivative":{"exercise_price":14.24,"expiration_date":"2028-10-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001127602-18-029912","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218029912/form4.xml","form_type":"4"}}]}